SPECIAL EMPHASIS PANELS
To view other meetings from ZDA1 choose calendar year:
Study Section | Panel Name | Meeting Rosters |
---|---|---|
ZDA1 SKP-X(J1) | NIDA AVANT-GARDE PROGRAM FOR HIV AND SUBSTANCE USE DISORDER RESEARCH; NIDA AVENIR AWARD PROGRAM FOR HIV AND SUBSTANCE USE DISORDER RESEARCH | 12/09/24 |
ZDA1 SKP-N(J1) | CUTTING-EDGE BASIC RESEARCH AWARDS (CEBRA) | 11/21/24 |
ZDA1 TXT-E(J1) | HIGH PRIORITY HIV AND SUBSTANCE USE RESEARCH | 11/20/24 |
ZDA1 DRO-N(J1) | FUNCTIONAL VALIDATION AND/OR CHARACTERIZATION OF GENES OR VARIANTS IMPLICATED IN SUBSTANCE USE DISORDERS AND NIDA ANIMAL GENOMICS PROGRAM | 11/19/24 |
ZDA1 CEM-N(J1) | MECHANISTIC STUDIES ON SOCIAL BEHAVIOR IN SUBSTANCE USE DISORDER | 11/19/24 |
ZDA1 LXF-T(J1) | NIH SUPPORT FOR CONFERENCES AND SCIENTIFIC MEETINGS | 11/19/24 |
ZDA1 IXR-N(J2) | MECHANISTIC RESEARCH ON NEUROMODULATION FOR SUD TREATMENT + USING NEUROMODULATION TO CHARACTERIZE THE CONTINUUM OF PATHOPHYSIOLOGY BETWEEN SUBSTANCE USE AND MENTAL HEALTH | 11/18/24 |
ZDA1 CEM-N(J2) | SCORCH (SINGLE CELL OPIOID RESPONSES IN THE CONTEXT OF HIV) PROGRAM: DATA COORDINATION, ANALYSIS, AND SCIENTIFIC OUTREACH; DATA MINING AND FUNCTIONAL VALIDATION | 11/15/24 |
ZDA1 TXT-E(J2) | ENDING THE EPIDEMIC: NEW MODELS OF INTEGRATED HIV/AIDS, ADDICTION, AND PRIMARY CARE SERVICES | 11/15/24 |
ZDA1 DRO-S(J1) | HARNESSING ARTIFICIAL INTELLIGENCE AND POLYPHARMACOLOGY TO DISCOVER PHARMACOTHERAPEUTICS FOR SUBSTANCE USE DISORDERS | 11/13/24 |
ZDA1 SUY-E(J1) | MECHANISM FOR TIME-SENSITIVE DRUG ABUSE RESEARCH | 11/12/24 |
ZDA1 SXC-N(J1) | EXPLORATORY STUDIES TO INVESTIGATE MECHANISMS OF HIV INFECTION, REPLICATION, LATENCY, AND/OR PATHOGENESIS IN THE CONTEXT OF SUBSTANCE USE DISORDERS | 11/07/24 |
ZDA1 SUY-S(J1) | DEVELOPING REGULATED THERAPEUTIC AND DIAGNOSTIC SOLUTIONS FOR PATIENTS AFFECTED BY OPIOID AND/OR STIMULANTS USE DISORDERS | 11/07/24 |
ZDA1 MXS-E(J1) | ENGAGING SURVIVORS OF SEXUAL VIOLENCE AND TRAFFICKING IN HIV AND SUBSTANCE USE DISORDER SERVICES | 11/06/24 |
ZDA1 SUY-M(J1) | NIDA-L CONFLICT SEP | 11/05/24 |
ZDA1 MXY-N(J1) | MICROGLIAL PATHOPHYSIOLOGY IN COMORBID SUBSTANCE USE DISORDER (SUD) AND HIV | 11/05/24 |
ZDA1 SAI-E(J1) | ADDRESSING HIV IN HIGHEST RISK SEXUAL AND GENDER MINORITIES | 11/04/24 |
ZDA1 SXC-E(J1) | COHORT STUDIES OF HIV/AIDS AND SUBSTANCE USE | 11/04/24 |
ZDA1 MXS-T(J1) | NIDA-K ALTERNATE SEP | 11/04/24 |
ZDA1 SKM-N(J1) | TRANSFORMATIVE RESEARCH ON THE BASIC MECHANISMS OF POLYSUBSTANCE USE IN ADDICTION | 11/01/24 |
ZDA1 TXT-M(J1) | ANALYTICAL SERVICE CENTER FOR MEDICATIONS DEVELOPMENT PROGRAM | 10/30/24 |
ZDA1 LXF-E(J1) | ACCELERATING THE PACE OF DRUG ABUSE RESEARCH USING EXISTING DATA | 10/30/24 |
ZDA1 PXN-M(J1) | DEVICE BASED TREATMENTS FOR SUBSTANCE USE DISORDERS | 10/30/24 |
ZDA1 IXR-N(J1) | EX VIVO MODELS FOR STUDIES AT THE INTERSECTION OF HIV AND POLY-SUBSTANCE USE | 10/22/24 |
ZDA1 MXY-N(J2) | CHEMICAL PROBES AND DRUGS FOR MODULATING HIV TRANSCRIPTION IN THE CONTEXT OF SUBSTANCE USE DISORDERS | 10/21/24 |
ZDA1 SAI-M(J2) | DEVELOPMENT OF CLINICAL OUTCOME ASSESSMENTS AS NEW FDA-QUALIFIED DRUG DEVELOPMENT TOOLS TO ACCELERATE THERAPEUTICS DEVELOPMENT FOR OPIOID AND STIMULANT USE DISORDERS | 09/18/24 |
ZDA1 SAI-M(J1) | DEVELOPING DIGITAL THERAPEUTICS FOR SUBSTANCE USE DISORDERS | 09/16/24 |
ZDA1 MXY-M(O2) | PHARMACOKINETIC ANALYSIS RESOURCE CENTER | 08/14/24 |
ZDA1 MXS-T(O2) | NIDA-K ALTERNATE SEP | 08/01/24 |
ZDA1 PXN-S(O1) | TOOLS FOR DECENTRALIZED CLINICAL TRIALS FOR SUBSTANCE USE DISORDER | 07/24/24 |
ZDA1 SUY-M(O2) | NIDA-L CONFLICT SEP | 07/23/24 |
ZDA1 MXY-M(O1) | GMP SYNTHESIS OF BULK DRUG TESTING | 07/18/24 |
ZDA1 SXC-M(O1) | PSYCHEDELICS TREATMENT RESEARCH IN SUBSTANCE USE DISORDER | 07/16/24 |
ZDA1 SKP-N(O1) | CUTTING-EDGE BASIC RESEARCH AWARDS (CEBRA) | 07/16/24 |
ZDA1 DRO-N(O1) | NIDA ANIMAL GENOMICS PROGRAM + FUNCTIONAL VALIDATION AND/OR CHARACTERIZATION OF GENES OR VARIANTS IMPLICATED IN SUBSTANCE USE DISORDERS | 07/12/24 |
ZDA1 SAI-C(O1) | THE NATIONAL DRUG ABUSE TREATMENT CLINICAL TRIALS NETWORK | 07/11/24 |
ZDA1 TXT-E(A1) | HIGH PRIORITY HIV AND SUBSTANCE USE RESEARCH | 07/11/24 |
ZDA1 CEM-E(O1) | ADOLESCENT OVERDOSE PREVENTION AND SUD TREATMENT INITIATIVE | 07/11/24 |
ZDA1 SXC-N(O1) | TARGETING INFLAMMASOMES IN HIV AND SUBSTANCE USE | 07/08/24 |
ZDA1 LXF-N(A1) | EDUCATION ACTIVITIES FOR RESPONSIBLE ANALYSES OF COMPLEX, LARGE-SCALE DATA | 07/03/24 |
ZDA1 SUY-E(O1) | MECHANISM FOR TIME?SENSITIVE DRUG ABUSE RESEARCH | 06/27/24 |
ZDA1 BSW-N(A1) | MECHANISTIC RESEARCH ON NEUROMODULATION FOR SUBSTANCE USE DISORDERS TREATMENT | 06/27/24 |
ZDA1 SKP-E(O1) | HEAL INITIATIVE: TRANSLATING RESEARCH TO PRACTICE TO END THE OVERDOSE CRISIS | 06/27/24 |
ZDA1 MXY-T(O1) | NIH SUPPORT FOR CONFERENCES AND SCIENTIFIC MEETINGS (R13) | 06/27/24 |
ZDA1 SAI-M(O1) | DEVELOPING DIGITAL THERAPEUTICS FOR SUBSTANCE USE DISORDERS | 06/25/24 |
ZDA1 CEM-N(O1) | INTEGRATED FUNCTIONAL MAPPING AND MOLECULAR PROFILING OF CELL ENSEMBLES ENCODING THE EFFECTS OF ADDICTIVE SUBSTANCES IN RODENTS | 06/13/24 |
ZDA1 SKM-S(O1) | SEEKING PRODUCTS TO ADDRESS SOCIAL NEEDS IMPACTING SUBSTANCE USE DISORDERS (SUD) | 06/10/24 |
ZDA1 MXS-T(O1) | NIDA-K ALTERNATE SEP | 06/06/24 |
ZDA1 DRO-N(A1) | BRAIN INITIATIVE: BRAIN-BEHAVIOR QUANTIFICATION AND SYNCHRONIZATION ? TRANSFORMATIVE AND INTEGRATIVE MODELS OF BEHAVIOR AT THE ORGANISMAL LEVEL | 06/06/24 |
ZDA1 SUY-T(A2) | ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS | 06/06/24 |
ZDA1 MXS-N(A1) | MECHANISTIC STUDIES OF THE EFFECTS OF PSYCHOSOCIAL STRESS ON COMPLEX MORBIDITY INVOLVING SUD, PSYCHIATRIC DISORDERS, AND HIV | 06/05/24 |
ZDA1 MXS-M(A1) | MEDICATION DISCOVERY USING RAT MODELS OF RELAPSE | 06/03/24 |
ZDA1 IXR-N(A1) | APPLYING IMAGING PIPELINES FOR SPATIAL CHARACTERIZATION OF CELLULAR INTERACTIONS IN HIV-RELATED CNS PATHOLOGY AND/OR SUBSTANCE USE | 05/31/24 |
ZDA1 LXF-E(A1) | ACCELERATING THE PACE OF DRUG ABUSE RESEARCH USING EXISTING DATA | 05/30/24 |
ZDA1 SUY-S(A1) | DEVELOPING REGULATED THERAPEUTIC AND DIAGNOSTIC SOLUTIONS FOR PATIENTS AFFECTED BY OPIOID AND/OR STIMULANTS USE DISORDERS (OUD/STUD) | 05/28/24 |
ZDA1 IXR-N(A2) | HEAL INITIATIVE: NOVEL TARGETS FOR OPIOID USE DISORDERS AND OPIOID OVERDOSE | 05/28/24 |
ZDA1 MXS-E(A1) | RURAL COMMUNITY-CENTERED DRUG MISUSE PREVENTION AND HARM REDUCTION RESEARCH: ADDRESSING IMPLEMENTATION, DISSEMINATION, AND EQUITY CHALLENGES ACROSS THE CONTINUUM OF CARE | 05/23/24 |
ZDA1 SAI-E(O1) | NATIONAL DRUG EARLY WARNING SYSTEM COORDINATING CENTER | 05/22/24 |
ZDA1 TXT-E(A2) | HEAL INITIATIVE: RESEARCH TO INCREASE IMPLEMENTATION OF SUBSTANCE USE PREVENTIVE SERVICES | 05/22/24 |
ZDA1 SXC-N(A1) | REI: TRAINING AND DIVERSIFYING THE DATA SCIENCE WORKFORCE FOR ADDICTION RESEARCH | 05/22/24 |
ZDA1 TXT-C(M1) | CLINICAL COORDINATING CENTER FOR NIDA?S CLINICAL TRIALS NETWORK | 05/20/24 |
ZDA1 SUY-E(M2) | NIDA REI- REACHING EQUITY AT THE INTERSECTION OF HIV AND SUBSTANCE USE: NOVEL APPROACHES TO ADDRESS HIV RELATED HEALTH DISPARITIES IN MINORITY POPULATIONS | 04/26/24 |
ZDA1 TXT-M(M1) | DEVICE-BASED TREATMENTS FOR SUBSTANCE USE DISORDERS | 03/28/24 |
ZDA1 SKP-E(M1) | RACIAL EQUITY VISIONARY AWARD PROGRAM FOR RESEARCH AT MINORITY SERVING INSTITUTIONS ON SUBSTANCE USE AND RACIAL EQUITY | 03/28/24 |
ZDA1 BSW-N(M1) | MECHANISTIC STUDIES TO INVESTIGATE THE INTERRELATIONSHIP BETWEEN SLEEP AND/OR CIRCADIAN RHYTHMS AND SUBSTANCE USE DISORDERS | 03/22/24 |
ZDA1 TXT-E(M1) | REACHING EQUITY AT THE INTERSECTION OF HIV AND SUBSTANCE USE: NOVEL APPROACHES TO ADDRESS HIV RELATED HEALTH DISPARITIES IN MINORITY POPULATIONS | 03/21/24 |
ZDA1 SUY-M(M1) | NIDA L CONFLICT SEP | 03/15/24 |
ZDA1 SAI-N(M1) | RESEARCH AT MINORITY SERVING INSTITUTIONS ON NEUROCOGNITIVE MECHANISMS UNDERLYING THE IMPACT OF STRUCTURAL RACISM ON THE SUBSTANCE USE TRAJECTORY | 03/14/24 |
ZDA1 SUY-E(M1) | MECHANISM FOR TIME-SENSITIVE DRUG ABUSE RESEARCH | 03/12/24 |
ZDA1 CEM-S(M1) | FIELD-DEPLOYABLE, LOW-COST POINT-OF-NEED APPROACHES AND TECHNOLOGIES TO LOWER THE BARRIERS TO SUBSTANCE USE DISORDERS (SUD) DIAGNOSIS AND TREATMENT | 03/06/24 |
ZDA1 SAI-M(M1) | DEVELOPING DIGITAL THERAPEUTICS FOR SUBSTANCE USE DISORDERS | 03/06/24 |
ZDA1 PXN-E(M1) | NIDA CENTERS GRANT PROGRAM | 03/06/24 |
ZDA1 IXR-M(M1) | QUANTIFICATION OF DRUGS OF ABUSE AND RELATED SUBSTANCES COMPOUNDS IN BIOLOGICAL SPECIMENS | 03/01/24 |
ZDA1 LXF-E(M1) | ACCELERATING THE PACE OF DRUG ABUSE RESEARCH USING EXISTING DATA | 02/29/24 |
ZDA1 SXC-E(M1) | NIDA RESEARCH CENTER OF EXCELLENCE GRANT PROGRAM & NIDA CORE "CENTER OF EXCELLENCE" GRANT PROGRAM | 02/26/24 |
ZDA1 IXR-X(M1) | NIH SUPPORT FOR CONFERENCES AND SCIENTIFIC MEETINGS | 02/22/24 |
ZDA1 BSW-N(M2) | ADVANCING PSYCHEDELICS RESEARCH FOR TREATING ADDICTION | 02/21/24 |
ZDA1 MXS-T(M1) | NIDA-K ALTERNATE SEP | 02/21/24 |
ZDA1 SXC-E(M2) | JCOIN METHODOLOGY CENTER (MAARC) & JCOIN COORDINATION CENTER (CTC) | 02/16/24 |
ZDA1 LXF-N(M1) | CHEMICAL COUNTERMEASURES RESEARCH PROGRAM INITIATIVE: RESEARCH ON COUNTERACTING THE DELETERIOUS EFFECTS OF ACUTE OPIOID EXPOSURE | 02/15/24 |
ZDA1 MXS-E(M1) | STIMULANTS AND HIV: ADDRESSING CONTEMPORARY AND RECURRING EPIDEMICS | 02/14/24 |
ZDA1 SKP-E(M2) | TRANSLATING RESEARCH TO PRACTICE TO END THE OVERDOSE CRISIS | 02/14/24 |
ZDA1 IXR-N(M1) | AVENIR AWARD PROGRAM FOR GENETICS OR EPIGENETICS OF SUBSTANCE USE DISORDERS | 02/14/24 |
ZDA1 CEM-N(M1) | TRANSLATING SOCIOENVIRONMENTAL INFLUENCES ON NEUROCOGNITIVE DEVELOPMENT AND ADDICTION RISK (TRANSINDA) | 02/09/24 |
ZDA1 SAI-E(M1) | PATIENT ENGAGEMENT RESOURCE CENTERS TO INFORM SUD TREATMENT SERVICES RESEARCH | 01/31/24 |
ZDA1 SKM-E(M1) | ADDRESSING RACIAL EQUITY IN SUBSTANCE USE AND ADDICTION RESEARCH THROUGH COMMUNITY-ENGAGED RESEARCH | 01/30/24 |
ZDA1 MXS-M(M1) | AVENIR AWARD PROGRAM FOR CHEMISTRY AND PHARMACOLOGY OF SUBSTANCE USE DISORDERS | 01/10/24 |